‘‘(2) With respect to the individuals who are 
tested for such an infection, to demonstrate success 
in increasing the number of individuals tested and 
made aware of their status, including those who test 
positive. 
‘‘(3) To develop and disseminate public infor-
mation and education programs for the detection 
and control of such infections. 
‘‘(4) To improve the education, training, and 
skills of health professionals in the detection, con-
trol, and care and treatment, of such infections. 
‘‘(5) To provide appropriate referrals for coun-
seling and medical care and treatment of infected in-
dividuals and to ensure, to the extent practicable, 
the provision of appropriate followup services. 
‘‘(c) HIGH-RISK POPULATIONS; CHRONIC CASES.— 
‘‘(1) IN GENERAL.—The Secretary shall deter-
mine the populations that, for purposes of this sec-
tion, are considered at high-risk for HBV or HCV. 
The Secretary shall include the following among 
those considered at high-risk: 
‘‘(A) For HBV, individuals born in coun-
tries in which 2 percent or more of the popu-
lation has HBV or who are a part of a high- 
risk category as identified by the Centers for 
VerDate Sep 11 2014 
23:26 Mar 06, 2015
Jkt 049200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H1101.IH
H1101
asabaliauskas on DSK5VPTVN1PROD with BILLS
Disease Control and Prevention and the United 
States Preventive Services Task Force. 
‘‘(B) For HCV, individuals born between 
1945 and 1965 or who are a part of a high-risk 
category as identified by the Centers for Dis-
ease Control and Prevention and the United 
States Preventive Services Task Force. 
‘‘(C) Those who have been exposed to the 
blood of infected individuals or of high-risk in-
dividuals or who are family members of such in-
dividuals. 
‘‘(2) PRIORITY IN PROGRAMS.—In providing for 
programs under this section, the Secretary shall give 
priority— 
‘‘(A) to early diagnosis of chronic cases of 
HBV or HCV in high-risk populations under 
paragraph (1); and 
‘‘(B) to education, and referrals for coun-
seling and medical care and treatment, for indi-
viduals diagnosed under subparagraph (A) in 
order to— 
‘‘(i) reduce their risk of dying from 
end-stage liver disease and liver cancer, 
and of transmitting the infection to others; 
VerDate Sep 11 2014 
23:26 Mar 06, 2015
Jkt 049200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H1101.IH
H1101
asabaliauskas on DSK5VPTVN1PROD with BILLS
‘‘(ii) determine the appropriateness 
for treatment to reduce the risk of progres-
sion to cirrhosis and liver cancer; 
‘‘(iii) receive ongoing medical manage-
ment, including regular monitoring of liver 
function and screenings for liver cancer; 
‘‘(iv) receive, as appropriate, drug, al-
cohol abuse, and mental health treatment; 
‘‘(v) in the case of women of child-
bearing age, receive education on how to 
prevent HBV perinatal infection, and to al-
leviate fears associated with pregnancy or 
raising a family; and 
‘‘(vi) receive such other services as the 
Secretary determines to be appropriate. 
‘‘(3) CULTURAL
CONTEXT.—In providing for 
services pursuant to paragraph (2) for individuals 
who are diagnosed under subparagraph (A) of such 
paragraph, the Secretary shall seek to ensure that 
the services are provided in a culturally and linguis-
tically appropriate manner. 
‘‘(d) ACTION PLAN IMPLEMENTATION.— 
‘‘(1) BENCHMARKS.—The Secretary shall de-
velop benchmarks for evaluating the effectiveness of 
the programs and activities conducted under the ‘Ac-
VerDate Sep 11 2014 
23:26 Mar 06, 2015
Jkt 049200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H1101.IH
H1101
asabaliauskas on DSK5VPTVN1PROD with BILLS
tion Plan for the Prevention, Care, & Treatment of 
Viral Hepatitis’ of the Department of Health and 
Human Services and make determinations as to 
whether such benchmarks have been achieved. 
‘‘(2) ANNUAL REPORTING.— 
‘‘(A) IN
GENERAL.—The Secretary shall 
report annually to the Congress on the bench-
marks developed under paragraph (1), including 
the amount of funding used by each agency of 
the Department of Health and Human Services 
to achieve each benchmark. 
‘‘(B) CONTENTS.—Each report under sub-
paragraph (A) shall include reporting on— 
‘‘(i) the number of people tested for 
hepatitis B and hepatitis C; 
‘‘(ii) the number of individuals who 
test positive for hepatitis B and C; 
‘‘(iii) the number of individuals who 
are tested and then made aware of their 
health status; 
‘‘(iv) the number of individuals re-
ferred to care or treatment followup; 
‘‘(v) improvements in surveillance ac-
tivities; 
VerDate Sep 11 2014 
23:26 Mar 06, 2015
Jkt 049200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H1101.IH
H1101
asabaliauskas on DSK5VPTVN1PROD with BILLS
‘‘(vi) provider and community edu-
cation activities; 
‘‘(vii) the reduction in the number of 
infants born with hepatitis B; 
‘‘(viii) estimates on the reduction, as 
a result of prevention measures, in the 
number of new hepatitis B and hepatitis C 
infections; and 
‘‘(ix) estimates on the reduction in 
liver cancer resulting from hepatitis B or 
hepatitis C infection. 
‘‘(e) PUBLIC-PRIVATE PARTNERSHIPS.— 
‘‘(1) IN GENERAL.—In carrying out this sec-
tion, and not later than 60 days after the date of 
the enactment of the Viral Hepatitis Testing Act of 
2015, the Secretary shall, in consultation with the 
Assistant Secretary for Health, the Director of the 
Centers for Disease Control and Prevention, the 
Health Resources and Services Administration, the 
Substance Abuse and Mental Health Services Ad-
ministration, the Office of Minority Health, the In-
dian Health Service, other relevant agencies, and 
nongovernment stakeholder entities, establish and 
support public-private partnerships that facilitate 
VerDate Sep 11 2014 
23:26 Mar 06, 2015
Jkt 049200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H1101.IH
H1101
asabaliauskas on DSK5VPTVN1PROD with BILLS
the surveillance, education, screening, testing, and 
linkage to care programs authorized by this section. 
‘‘(2) DUTIES.—Public-private partnerships es-
tablished or supported under paragraph (1) shall— 
‘‘(A) focus primarily on the surveillance, 
education, screening, testing, and linkage to 
care programs authorized by this section; 
‘‘(B) generate resources, in addition to the 
funds made available pursuant to subsection 
(f), to carry out the surveillance, education, 
screening, testing, and linkage to care programs 
authorized in this section by leveraging Federal 
funding with non-Federal funding and support; 
‘‘(C) allow for investments in such pro-
grams of financial or in-kind resources by each 
of the partners involved in the partnership; 
‘‘(D) include corporate and industry enti-
ties, academic institutions, public and nonprofit 
organizations, community and faith-based orga-
nizations, foundations, and other governmental 
and nongovernmental organizations; and 
‘‘(E) advance the core goals of each of the 
partners of the partnership as determined by 
the Secretary in development of the partner-
ship. 
VerDate Sep 11 2014 
23:26 Mar 06, 2015
Jkt 049200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H1101.IH
H1101
asabaliauskas on DSK5VPTVN1PROD with BILLS